Skip to main content

Table 1 Baseline clinical characteristics of patients with central retinal vein occlusion without macular edema

From: Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema

 

Observation group

IVD-treated group

p-value

Patients/ eyes (N)

10/10

10/10

N/A

Sex, female/ maleb (N)

9/2

7/2

0.38

Involved eye, right/ leftb (N)

6/5

3/6

0.67

Mean agea (y)

51.7 ± 20.7

43.2 ± 12.2

0.15

Hypertensionb (N (%))

3 (27.3)

1 (11.1)

0.36

Type 2 diabetesb (N (%))

2 (18.2)

1 (11.1)

0.88

Hypercoagulopathy (N (%))

0 (0)

0 (0)

N/A

Systemic autoimmune/inflammation (N (%))

0 (0)

0 (0)

N/A

Mean BCVAa (logMAR)

0.11 ± 0.23

0.12 ± 0.33

0.61

Mean IOPa (mmHg)

14.3 ± 2.0

12.0 ± 3.2

0.44

Spherical equivalenta (diopter)

−0.60 ± 0.53

−0.89 ± 0.34

0.27

Mean duration of the diseasea (weeks)

3.6 ± 4.6

3.8 ± 3.3

0.06

  1. Values are presented as mean ± standard deviation
  2. IVD intravitreal dexamethasone, BCVA best-corrected visual acuity, IOP intraocular pressure
  3. aMann-Whitney U test and bFisher’s exact test were used for analysis